- Home
- Publications
- Publication Search
- Publication Details
Title
Prospects for RNAi Therapy of COVID-19
Authors
Keywords
-
Journal
Frontiers in Bioengineering and Biotechnology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-30
DOI
10.3389/fbioe.2020.00916
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation
- (2020) Simon Dirmeier et al. PLoS Computational Biology
- MiR-10a-5p-Mediated Syndecan 1 Suppression Restricts Porcine Hemagglutinating Encephalomyelitis Virus Replication
- (2020) Shiyu Hu et al. Frontiers in Microbiology
- Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
- (2020) Ning Wang et al. Frontiers in Microbiology
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium
- (2020) Haijun Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic
- (2020) Konstantinos Parperis ANNALS OF THE RHEUMATIC DISEASES
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Current pharmacological treatments for COVID‐19: What's next?
- (2020) Cristina Scavone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Hydroxychloroquine for Treatment of SARS‐CoV‐2 Infection? Improving Our Confidence in a Model‐Based Approach to Dose Selection
- (2020) Samuel L.M. Arnold et al. CTS-Clinical and Translational Science
- Chloroquine for COVID-19 Infection
- (2020) Nicholas Moore DRUG SAFETY
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
- (2020) Yang Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
- (2020) Dan Zhou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein
- (2020) Tahir S Pillay JOURNAL OF CLINICAL PATHOLOGY
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
- (2020) Zhaohai Zheng et al. JOURNAL OF INFECTION
- The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections
- (2020) Farhana Musarrat et al. JOURNAL OF MEDICAL VIROLOGY
- Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
- (2020) Huan Li et al. LEUKEMIA
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Laboratory testing of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges, and countermeasures
- (2020) Ying Yan et al. REVIEWS IN MEDICAL VIROLOGY
- ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
- (2020) Li Xiao et al. Viruses-Basel
- Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin
- (2020) José Millán-Oñate et al. Annals of Clinical Microbiology and Antimicrobials
- Alveolar wars: The rise of in vitro models to understand human lung alveolar maintenance, regeneration, and disease
- (2020) Kelly V. Evans et al. Stem Cells Translational Medicine
- Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
- (2020) Gian Paolo Rossi et al. eLife
- Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
- (2020) Juan Simon Rico-Mesa et al. Current Cardiology Reports
- Computational Identification of Small Interfering RNA Targets in SARS-CoV-2
- (2020) Wei Chen et al. VIROLOGICA SINICA
- Genetic diversity and evolution of SARS-CoV-2
- (2020) Tung Phan INFECTION GENETICS AND EVOLUTION
- Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
- (2020) Zhe Zhu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Developing spray-freeze-dried particles containing a hyaluronic acid-coated liposome–protamine–DNA complex for pulmonary inhalation
- (2020) Kaori Fukushige et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Vaccines against Coronaviruses: The State of the Art
- (2020) Cristiano Conte et al. Vaccines
- Vaccination strategies to combat novel corona virus SARS-CoV-2
- (2020) Satish Chandra Pandey et al. LIFE SCIENCES
- Establishment of an Evaluation Method for Gene Silencing by Serial Pulmonary Administration of siRNA and pDNA Powders: Naked siRNA Inhalation Powder Suppresses Luciferase Gene Expression in the Lung
- (2019) Takaaki Ito et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress
- (2019) Kamal Dua et al. DRUG DEVELOPMENT RESEARCH
- miR-142a-3p promotes the proliferation of porcine hemagglutinating encephalomyelitis virus by targeting Rab3a
- (2019) Peng Fan et al. ARCHIVES OF VIROLOGY
- Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors
- (2018) Jeanne M. Sisk et al. JOURNAL OF GENERAL VIROLOGY
- Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy
- (2018) Pieterjan Merckx et al. Acta Biomaterialia
- Understanding the principle biophysics concepts of pulmonary surfactant in health and disease
- (2018) Chiara Autilio et al. Archives of Disease in Childhood-Fetal and Neonatal Edition
- Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins
- (2018) Roberta Guagliardo et al. JOURNAL OF CONTROLLED RELEASE
- The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease
- (2017) Gerald Burgstaller et al. EUROPEAN RESPIRATORY JOURNAL
- Nucleic acid combinations: A new frontier for cancer treatment
- (2017) Remant Bahadur K.C. et al. JOURNAL OF CONTROLLED RELEASE
- Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication
- (2017) Eveline Kindler et al. PLoS Pathogens
- Airway Memory CD4 + T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
- (2016) Jincun Zhao et al. IMMUNITY
- Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine
- (2016) Bo Li et al. International Journal of Nanomedicine
- Current prospects and future challenges for nasal vaccine delivery
- (2016) Helmy Yusuf et al. Human Vaccines & Immunotherapeutics
- The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of RNA Silencing in Mammalian Cells
- (2015) Lei Cui et al. JOURNAL OF VIROLOGY
- Genome-Wide Screen Reveals Valosin-Containing Protein Requirement for Coronavirus Exit from Endosomes
- (2015) Hui Hui Wong et al. JOURNAL OF VIROLOGY
- Inhalable nanoparticulate powders for respiratory delivery
- (2015) Priya Muralidharan et al. Nanomedicine-Nanotechnology Biology and Medicine
- SARS-Coronavirus Open Reading Frame-9b Suppresses Innate Immunity by Targeting Mitochondria and the MAVS/TRAF3/TRAF6 Signalosome
- (2014) Chong-Shan Shi et al. JOURNAL OF IMMUNOLOGY
- The ORF4a protein of human coronavirus 229E functions as a viroporin that regulates viral production
- (2013) Ronghua Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells
- (2013) H M Aliabadi et al. CANCER GENE THERAPY
- Unconventional roles of nonlipidated LC3 in ERAD tuning and coronavirus infection
- (2012) Riccardo Bernasconi et al. Autophagy
- Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain
- (2012) Martha Schneider et al. JOURNAL OF VIROLOGY
- Identification and Characterization of Three Novel Small Interference RNAs That Effectively Down-Regulate the Isolated Nucleocapsid Gene Expression of SARS Coronavirus
- (2011) Ying-Li Cao et al. MOLECULES
- Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine
- (2011) Lissette S. Velasquez et al. VACCINE
- A structural analysis of M protein in coronavirus assembly and morphology
- (2010) Benjamin W. Neuman et al. JOURNAL OF STRUCTURAL BIOLOGY
- The 7a Accessory Protein of Severe Acute Respiratory Syndrome Coronavirus Acts as an RNA Silencing Suppressor
- (2010) S. Karjee et al. JOURNAL OF VIROLOGY
- Lipid and hydrophobic modification of cationic carriers on route to superior gene vectors
- (2010) Vanessa Incani et al. Soft Matter
- Differential characteristics of the early stage of lung inflammation induced by SARS-CoV Nucleocapsid protein related to age in the mouse
- (2009) Y. G. Zhu et al. INFLAMMATION RESEARCH
- Identification of In Vivo-Interacting Domains of the Murine Coronavirus Nucleocapsid Protein
- (2009) K. R. Hurst et al. JOURNAL OF VIROLOGY
- The Open Reading Frame 3a Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Promotes Membrane Rearrangement and Cell Death
- (2009) E. C. Freundt et al. JOURNAL OF VIROLOGY
- Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection
- (2009) J. Chen et al. JOURNAL OF VIROLOGY
- MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins
- (2009) Yu Lei et al. PLoS One
- Severe Acute Respiratory Syndrome Coronavirus Protein 6 Accelerates Murine Hepatitis Virus Infections by More than One Mechanism
- (2008) S. Hussain et al. JOURNAL OF VIROLOGY
- Pathogenetic mechanisms of severe acute respiratory syndrome
- (2007) Yong Guo et al. VIRUS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started